| Literature DB >> 26273602 |
Rosemary Hiscock1, Fiona Dobbie2, Linda Bauld2.
Abstract
Smokers from lower socioeconomic groups are less likely to be successful in stopping smoking than more affluent smokers, even after accessing cessation programmes. Data were analysed from 3057 clients of nine services. Routine monitoring data were expanded with CO validated smoking status at 52-week follow-up. Backwards logistic regression modelling was used to consider which factors were most important in explaining the relationship between SES and quitting. The odds ratio of stopping smoking among more affluent clients, compared with more disadvantaged clients, after taking into account design variables only, was 1.85 (95% CI 1.44 to 2.37) which declined to 1.44 (1.11 to 1.87) when all controls were included. The factors that explained more than 10% of the decline in the odds ratio were age, proportion of friends and family who smoked, nicotine dependence, and taking varenicline. A range of factors contribute to lower cessation rates for disadvantaged smokers. Some of these can be modified by improved smoking cessation service provision, but others require contributions from wider efforts to improve material, human, and social capital.Entities:
Mesh:
Year: 2015 PMID: 26273602 PMCID: PMC4529910 DOI: 10.1155/2015/274056
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Distribution and CO validated quit rates among SES indicators.
|
| % | % CO validated quit at 52 weeks (weighted) | |
|---|---|---|---|
| NSSEC–economic status | |||
| Routine and manual occupations∗ | 939 | 30.7 | 6.5 (4.7 to 8.9) |
| Managerial/professional and intermediate occupations | 716 | 23.4 | 9.3 (6.0 to 14.0) |
| Sick/disabled and never worked/long term unemployed∗ | 660 | 21.6 | 6.8 (4.7 to 9.9) |
| Other (e.g., retired)/unknown | 742 | 24.3 | 8.5 (6.6 to 10.8) |
| Highest educational qualification | |||
| Basic (GCSE) or none∗ | 1452 | 47.5 | 7.1 (5.5 to 9.3) |
| Other (e.g., vocational)/unknown | 1000 | 32.7 | 8.2 (5.8 to 11.6) |
| A level or degree | 605 | 19.8 | 8.6 (6.0 to 12.1) |
| Eligibility for free prescriptions | |||
| Free∗ | 1433 | 46.9 | 6.3 (5.1 to 7.9) |
| Pays | 1080 | 35.3 | 8.4 (6.1 to 11.4) |
| Outside relevant age range (19–59) or unknown | 544 | 17.8 | 9.7 (7.6 to 12.5) |
| Housing tenure | |||
| Social/private renting∗ | 1487 | 48.6 | 6.1 (4.9 to 7.4) |
| Other/unknown | 316 | 10.3 | 4.1 (1.3 to 12.6) |
| Owner occupier | 1254 | 41.0 | 10.8 (9.3 to 12.5) |
| Household type | |||
| Single parent∗ | 309 | 10.1 | 5.1 (2.3 to 10.9) |
| Married/cohabiting and children | 664 | 21.7 | 9.4 (5.8 to 14.8) |
| No children in household | 1832 | 59.9 | 7.9 (7.0 to 8.9) |
| Other/unknown | 252 | 8.2 | 4.7 (1.6 to 13.3) |
| Total | 3057 | 100.0 | 7.7 (6.6 to 9.0) |
∗These categories were included in the count of markers of disadvantage.
ELONS 52-week weighted CO validated quit rates (percents and weighted 95% CI), weighted means of age and wellbeing (and weighted 95% CI) by key variables∗.
|
| % | % CO validated quit at 52 weeks | % disadvantaged | |
|---|---|---|---|---|
| (95% CI) | (95% CI) | |||
| (weighted) | (weighted) | |||
| SES | ||||
| 0-1 indicators of disadvantage | 1123 | 36.7 | 10.3 (8.4 to 12.7) | 0 |
| 2–5 indicators of disadvantage | 1934 | 63.3 | 6.2 (5.0 to 7.7) | 100 |
| Behavioural support | ||||
| Group specialist | 652 | 21.3 | 12.1 (10.5 to 13.8) | 57.5 (46.8 to 67.6) |
| Drop in specialist | 887 | 29.0 | 7.6 (5.1 to 11.0) | 70.3 (63.7 to 76.2) |
| One to one specialist | 1131 | 37.0 | 10.2 (7.6 to 13.7) | 64.1 (55.0 to 72.2) |
| GP practice/pharmacy service | 366 | 12.0 | 5.1 (2.8 to 9.3) | 60.1 (53.7 to 66.2) |
| Other or unknown | 21 | .7 | Not available | Not available |
| Time of year of quit attempt | ||||
| Other months | 767 | 25.1 | 7.0 (5.2 to 9.4) | 61.7 (55.3 to 67.6) |
| Summer: July, August | 970 | 31.7 | 6.3 (4.4 to 8.9) | 64.3 (56.4 to 71.5) |
| Back to school: September, October | 1128 | 36.9 | 8.7 (6.4 to 11.7) | 65.6 (61.1 to 69.8) |
| New Year: January, February | 192 | 6.3 | 13.1 (5.1 to 29.6) | 51.5 (29.5 to 73.0) |
| Age (in years) |
|
| ||
| (weighted mean) |
|
| ||
| Gender | ||||
| Female | 1710 | 55.9 | 7.2 (6.0 to 8.5) | 64.0 (59.6 to 68.2) |
| Male | 1347 | 44.1 | 8.4 (6.8 to 10.2) | 62.4 (56.1 to 68.3) |
| WHO_5 Wellbeing |
|
| ||
| (weighted mean) |
|
| ||
| Medication in week 1 | ||||
| Varenicline not recorded | 1661 | 54.3 | 6.2 (4.9 to 7.7) | 66.3 (60.7 to 71.5) |
| Took varenicline | 1396 | 45.7 | 10.0 (7.2 to 13.8) | 58.8 (50.8 to 66.4) |
| Dependence | ||||
| Other | 1681 | 55.0 | 9.8 (7.7 to 12.4) | 57.9 (53.2 to 62.4) |
| Highly dependent | 1376 | 45.0 | 4.9 (2.9 to 8.2) | 70.5 (65.9 to 74.7) |
| Support from spouse partner | ||||
| Other | 1507 | 49.3 | 6.2 (4.5 to 8.5) | 67.1 (60.7 to 72.9) |
| Support from spouse/partner | 1550 | 50.7 | 9.2 (7.4 to 11.3) | 59.6 (54.3 to 64.6) |
| Friends and family | ||||
| Other | 771 | 25.2 | 3.4 (2.6 to 4.4) | 75.2 (66.5 to 82.3) |
| Half or fewer smoke | 2286 | 74.8 | 9.1 (7.5 to 10.9) | 59.5 (55.3 to 63.6) |
| Base |
|
|
|
|
∗Significant differences in SES but not quitting by location (not shown).
52-week adjusted odds ratios (and 95% CI) by key variables and OR (95% CI) of disadvantaged SES is models varying the entry of other variables.
| Adjusted odds ratios in full model | Odds ratio (95% CI) of CO validated quitting for low SES clients (2 to 5 indicators of disadvantage) compared to more affluent clients (0 to 1 indicators of disadvantage) | |
|---|---|---|
| SES only entered | 1.93 (1.51 to 2.47) | |
| Design variable∗ model | 1.85 (1.44 to 2.38) | |
| SES | ||
| 0-1 indicators of low SES | 1.4 (1.1 to 1.9) | 1.44 (1.11 to 1.87) |
| 2–5 indicators of low SES | 1 | |
| Age (in years)∗ | 1.011 (1.002 to 1.020) |
|
| Gender | 1.43 (1.10 to 1.86) | |
| Female | 1 | |
| Male | 1.2 (0.9 to 1.5) | |
| Seasonality | 1.43 (1.10 to 1.86) | |
| Other months | 1.2 (0.8 to 1.7) | |
| Summer: July, August | 1 | |
| Back to school: September, October | 1.2 (0.9 to 1.6) | |
| New Year: January, February | 1.7 (1.0 to 2.9) | |
| Wellbeing | 1.007 (1.0003 to 1.013) | 1.47 (1.13 to 1.91) |
| Dependence |
| |
| Other | 1.5 (1.1 to 1.9) | |
| Highly dependent | 1 | |
| Support from spouse partner | 1.47 (1.14 to 1.91) | |
| Other | 1.0 | |
| Support from spouse/partner | 1.4 (1.0 to 1.8) | |
| Social network |
| |
| Other | 1.0 | |
| Half or fewer smoke | 2.0 (1.4 to 2.9) | |
| Medication |
| |
| Varenicline not recorded | 1 | |
| Took varenicline | 1.7 (1.3 to 2.3) |
∗Design variable model includes behavioural support type and location due to differential recruitment.
Bold area indicates variable passed the threshold (calculated as 1.48) of being relevant in the relationship between SES and CO validated quitting.